These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 21835222)
1. SAHA/TRAIL combination induces detachment and anoikis of MDA-MB231 and MCF-7 breast cancer cells. Lauricella M; Ciraolo A; Carlisi D; Vento R; Tesoriere G Biochimie; 2012 Feb; 94(2):287-99. PubMed ID: 21835222 [TBL] [Abstract][Full Text] [Related]
2. HPW-RX40 restores anoikis sensitivity of human breast cancer cells by inhibiting integrin/FAK signaling. Chen IH; Shih HC; Hsieh PW; Chang FR; Wu YC; Wu CC Toxicol Appl Pharmacol; 2015 Dec; 289(2):330-40. PubMed ID: 26386190 [TBL] [Abstract][Full Text] [Related]
3. The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAIL. Butler LM; Liapis V; Bouralexis S; Welldon K; Hay S; Thai le M; Labrinidis A; Tilley WD; Findlay DM; Evdokiou A Int J Cancer; 2006 Aug; 119(4):944-54. PubMed ID: 16550602 [TBL] [Abstract][Full Text] [Related]
4. Itch/AIP4-independent proteasomal degradation of cFLIP induced by the histone deacetylase inhibitor SAHA sensitizes breast tumour cells to TRAIL. Yerbes R; López-Rivas A Invest New Drugs; 2012 Apr; 30(2):541-7. PubMed ID: 21107885 [TBL] [Abstract][Full Text] [Related]
5. The histone deacetylase inhibitor suberoylanilide hydroxamic acid sensitises human hepatocellular carcinoma cells to TRAIL-induced apoptosis by TRAIL-DISC activation. Carlisi D; Lauricella M; D'Anneo A; Emanuele S; Angileri L; Di Fazio P; Santulli A; Vento R; Tesoriere G Eur J Cancer; 2009 Sep; 45(13):2425-38. PubMed ID: 19643600 [TBL] [Abstract][Full Text] [Related]
6. Roscovitine sensitizes breast cancer cells to TRAIL-induced apoptosis through a pleiotropic mechanism. Ortiz-Ferrón G; Yerbes R; Eramo A; López-Pérez AI; De Maria R; López-Rivas A Cell Res; 2008 Jun; 18(6):664-76. PubMed ID: 18458681 [TBL] [Abstract][Full Text] [Related]
7. The sesquiterpene lactone eupatolide sensitizes breast cancer cells to TRAIL through down-regulation of c-FLIP expression. Lee J; Hwangbo C; Lee JJ; Seo J; Lee JH Oncol Rep; 2010 Jan; 23(1):229-37. PubMed ID: 19956887 [TBL] [Abstract][Full Text] [Related]
8. Chemotherapy augments TRAIL-induced apoptosis in breast cell lines. Keane MM; Ettenberg SA; Nau MM; Russell EK; Lipkowitz S Cancer Res; 1999 Feb; 59(3):734-41. PubMed ID: 9973225 [TBL] [Abstract][Full Text] [Related]
9. Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice. Shankar S; Davis R; Singh KP; Kurzrock R; Ross DD; Srivastava RK Mol Cancer Ther; 2009 Jun; 8(6):1596-605. PubMed ID: 19509267 [TBL] [Abstract][Full Text] [Related]
10. Restoration of TRAIL-induced apoptosis in resistant human pancreatic cancer cells by a novel FAK inhibitor, PH11. Dao P; Smith N; Scott-Algara D; Garbay C; Herbeuval JP; Chen H Cancer Lett; 2015 Apr; 360(1):48-59. PubMed ID: 25684663 [TBL] [Abstract][Full Text] [Related]
12. Protective effect of RIP and c-FLIP in preventing liver cancer cell apoptosis induced by TRAIL. Sun J; Luo H; Nie W; Xu X; Miao X; Huang F; Wu H; Jin X Int J Clin Exp Pathol; 2015; 8(6):6519-25. PubMed ID: 26261530 [TBL] [Abstract][Full Text] [Related]
13. [Knockdown of TRAIL-DR5 gene inhibits autophagy of ER-positive MCF-7 breast cancer cells induced by SAHA]. Han H; Zhou H; Sun W; Liu C; Hou X; Zhou W Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Nov; 33(11):1504-1510. PubMed ID: 29268854 [TBL] [Abstract][Full Text] [Related]
14. SAHA-sensitized prostate cancer cells to TNFalpha-related apoptosis-inducing ligand (TRAIL): mechanisms leading to synergistic apoptosis. Lakshmikanthan V; Kaddour-Djebbar I; Lewis RW; Kumar MV Int J Cancer; 2006 Jul; 119(1):221-8. PubMed ID: 16450389 [TBL] [Abstract][Full Text] [Related]
15. Carnosic acid sensitized TRAIL-mediated apoptosis through down-regulation of c-FLIP and Bcl-2 expression at the post translational levels and CHOP-dependent up-regulation of DR5, Bim, and PUMA expression in human carcinoma caki cells. Jung KJ; Min KJ; Bae JH; Kwon TK Oncotarget; 2015 Jan; 6(3):1556-68. PubMed ID: 25596735 [TBL] [Abstract][Full Text] [Related]
16. The coffee diterpene kahweol sensitizes TRAIL-induced apoptosis in renal carcinoma Caki cells through down-regulation of Bcl-2 and c-FLIP. Um HJ; Oh JH; Kim YN; Choi YH; Kim SH; Park JW; Kwon TK Chem Biol Interact; 2010 Jun; 186(1):36-42. PubMed ID: 20403343 [TBL] [Abstract][Full Text] [Related]
17. Combined treatment with Ad-hTRAIL and DTIC or SAHA is associated with increased mitochondrial-mediated apoptosis in human melanoma cell lines. Lillehammer T; Engesaeter BO; Prasmickaite L; Maelandsmo GM; Fodstad O; Engebraaten O J Gene Med; 2007 Jun; 9(6):440-51. PubMed ID: 17410615 [TBL] [Abstract][Full Text] [Related]
18. Apoptosis induction by SAHA in cutaneous T-cell lymphoma cells is related to downregulation of c-FLIP and enhanced TRAIL signaling. Al-Yacoub N; Fecker LF; Möbs M; Plötz M; Braun FK; Sterry W; Eberle J J Invest Dermatol; 2012 Sep; 132(9):2263-74. PubMed ID: 22551975 [TBL] [Abstract][Full Text] [Related]
19. Death receptor 4 (DR4) efficiently kills breast cancer cells irrespective of their sensitivity to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Kazhdan I; Marciniak RA Cancer Gene Ther; 2004 Oct; 11(10):691-8. PubMed ID: 15354201 [TBL] [Abstract][Full Text] [Related]